Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-02

Clinical Trial Update: A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg

View source ↗

Summary

A post-market cohort study assesses the performance of the Spinal Modulation Neurostimulator System for managing chronic neuropathic pain of the foot and/or low…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal Modulation Neurostimulator System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Neuropathic Pain | Status: TERMINATED | Results posted: 2017-08-02